Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC

about

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC

Item

http://www.wikidata.org/entity/Q46946895

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC

@en

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC

@nl

type

Item

label

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC

@en

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC

@nl

prefLabel

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC

@en

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC

@nl

P1476

Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC

@en

P2093

Mohamed EL-Shafey

http://www.w3.org/2001/XMLSchema#string

Mohamed El-Dosoky

http://www.w3.org/2001/XMLSchema#string

Sally Abed

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating and hepatic Fas expression in HCV-induced chronic liver disease and hepatocellular carcinoma

Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4

Diagnosis, staging and treatment of hepatocellular carcinoma.

From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways.

Doppler in hepatic cirrhosis and chronic hepatitis.

Apoptosis: a mechanism of acute and chronic liver injury

Targeting the Fas/Fas ligand pathway in cancer.

Immunobiology and pathogenesis of viral hepatitis.

Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.

Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response.

P304

2683-2688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.22034/APJCP.2017.18.10.2683

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maysaa El Sayed Zaki

P577

2017-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29072392

http://www.w3.org/2001/XMLSchema#string

P932

5747390

http://www.w3.org/2001/XMLSchema#string